Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7994)
All Articles published online
|
Publishing Process of This Article
|
Dec 27, 2019 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim JJ, Park YJ, Moon KY, Park JH, Jeong YK, Kim EY. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock. World J Gastrointest Surg 2019; 11(12): 422-432 [PMID: 31879534 DOI: 10.4240/wjgs.v11.i12.422] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6255/full/v11/i12/422.htm |
| Number | Citing Articles |
| 1 |
Sergio Garcia-Ramos, Estrela Caamaño, Patrocinio Rodríguez Benítez, Pilar Benito, Alberto Calvo, Silvia Ramos, Mercedes Power, Ignacio Garutti, Patricia Piñeiro. Mortality Risk Prediction in Abdominal Septic Shock Treated with Polymyxin-B Hemoperfusion: A Retrospective Cohort Study. Journal of Personalized Medicine 2023; 13(7): 1023 doi: 10.3390/jpm13071023
|
| 2 |
Chao Li, Jinlian Zhang, Ping Yang, Ranran Wang, Ting Chen, Lixia Li. The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: A systematic review and meta-analysis. Heliyon 2024; 10(13): e33735 doi: 10.1016/j.heliyon.2024.e33735
|
| 3 |
Salvatore Lucio Cutuli, Silvia De Rosa, Ricard Ferrer, Juan Carlos Ruiz‐Rodriguez, Francesco Forfori, Claudio Ronco, Massimo Antonelli. Endotoxin activity trend and multi‐organ dysfunction in critically ill patients with septic shock, who received Polymyxin‐B hemadsorption: A multicenter, prospective, observational study. Artificial Organs 2023; 47(8): 1361 doi: 10.1111/aor.14534
|
| 4 |
Alice Bernard, Michael Koeppen. Extrakorporale Verfahren bei der Sepsis. Die Anaesthesiologie 2024; 73(10): 713 doi: 10.1007/s00101-024-01464-8
|
| 5 |
Yinan Jia, Li Zhang, Junhua Xu, Lin Xiang. Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection. Biomedical Materials 2024; 19(4): 042006 doi: 10.1088/1748-605X/ad46d4
|
| 6 |
Gaurav Pandey, Indranil Ghosh, Sukhwinder Sangha, Atul Srivastava. Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis. Indian Journal of Critical Care Medicine 2024; 28(10): 930 doi: 10.5005/jp-journals-10071-24805
|
| 7 |
Claudio Ronco, Thiago Reis. Continuous renal replacement therapy and extended indications. Seminars in Dialysis 2021; 34(6): 550 doi: 10.1111/sdi.12963
|
| 8 |
Won Young Lee, Hee Ju Kim, Eun Young Kim. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03055-8
|
| 9 |
Hye Sung Kim, Yoon Ji Chung, Gyeo Ra Lee, Eun Young Kim. The clinical efficacy and suitable implementation of two extracorporeal blood purification therapies: AN69-oXiris versus PMX-HP. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1344893
|